A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
Palermo, Sicilia, Italy
University hospital in Palermo
Via del Vespro, 129, 90127 Palermo PA
About A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
During the past decade, A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista
2020-08-25
2024-08-12
Active, not recruiting
152
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
2021-04-26
2025-02-05
Recruiting
554
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
According to Clinical.Site data, the most researched conditions in "A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia" are
"Carcinoma, Hepatocellular" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia" in a lesser frequency.
Clinical Trials Intervention Types at A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
Most popular intervention types in "A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (1 trials), "Lenvatinib" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
The vast majority of trials in "A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia" are
2 trials for "All" genders.
Clinical Trials Status at A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia
Currently, there are NaN active trials in "A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in A.O.U. Policlinico Paolo Giaccone; Gastroenterologia ed Epatologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".